Welcome to European Pharmaceutical Review. This site uses cookies. Read our policy.

  • Skip to main content
  • Skip to navigation
Site name
Site name
Mast navigation
  • Become a member
  • Sign In
Search our site
Menu
Close menu
  • Home
  • News
  • Bioprocessing
  • QA
  • Topics
    • Back to parent navigation item
    • Topics
    • Analytical and bioanalysis
    • Bioprocessing and biomanufacturing
    • Quality, microbiology and contamination control
    • Regulation and compliance
    • Formulation and drug delivery
    • Packaging, containers and labelling
  • Webinars
  • Whitepapers
  • Reports
  • Publications
  • Home
  • News
  • Bioprocessing
  • QA
  • Topics
      • Analytical and bioanalysis
      • Bioprocessing and biomanufacturing
      • Quality, microbiology and contamination control
      • Regulation and compliance
      • Formulation and drug delivery
      • Packaging, containers and labelling
    • shutterstock_2093455450
      Eli Lilly doubles down on supply chain investment in Asia
    • shutterstock_1569359980
      Gilead adds to cell therapy portfolio with $8bn acquisition of Arcellx
    • Image
      Fujifilm's Lars Petersen on trust-based partnerships and a ‘people first’ culture
  • Webinars
  • Whitepapers
  • Reports
  • Publications
  • More navigation items

A to Z subjects

Find stories by subject. Use the A-Z options to view other subjects.

  • A to Z subjects
  • A to Z contributors
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z
  • 0-9
  • All
J
  • J. Alex Kelly
  • Jacob Sten Petersen
  • Jacob Van Naarden
  • Jacqueline Barry (CGT Catapult)
  • Jan van de Winkel
  • Jane Wall
  • Janssen
  • Janssen EMEA
  • Janssen Pharmaceutical Companies of Johnson & Johnson
  • Janssen Pharmaceuticals
  • Janus kinase (JAK) inhibitors
  • Japanese Pharmacopoeia
  • Jardiance
  • Jascayd (nerandomilast)
  • Jason Jones
  • Jasper Morley
  • Javier López-Belmonte
  • Jay Benson
  • Jay Bradner
  • Jay Hagan
  • Jay Patel
  • Jaypirca
  • Jaypirca™ (pirtobrutinib)
  • Jean-Charles Wirth
  • Jean-Christophe Tellier
  • Jean-Francois Toussaint
  • Jean-Luc Herbeaux
  • Jemperli (dostarlimab)
  • Jennifer Taubert
  • Jerry Chih Wei Yu
  • Jessica Rayser (Accugenix)
  • Jessicca Rege (Alkermes)
  • Jessika Roswall
  • Jialin Xiang
  • Jiangsu Hengrui Pharmaceuticals Co.
  • Jihye Heo (Samsung Biologics)
  • Jim Fox
  • Jinzi Jason Wu
  • Jivi
  • JNJ-2113
  • Joanna Dempsey
  • Joaquin Duato
  • Joe Edwards
  • Joelle Fathi
  • Johan Carlsson (Swedish Medical Products Agency)
  • Johan Kahlström
  • John C. Reed
  • John Crowley
  • John Murphy III
  • John Oyler
  • John Rim
  • Johns Hopkins University
  • Johns Hopkins University School of Medicine
  • Johnson & Johnson
  • Johnson & Johnson Innovative Medicine
  • Johnson and Johnson
  • Jon Kallay (Charles River)
  • Jonathan Reynolds
  • Josefine Sommer (Sidley Austin)
  • JRS Pharma
  • JSKN-003
  • JSR Life Sciences
  • Jubbonti® (denosumab-bddz)
  • Julia Matros
  • Julia Schueler
  • Julian Beach
  • Julie Anderson
  • Julie Huynh (Gelteq)
  • Julie Kim
  • Julien Dodet
  • Juliette White
  • Julius Clinical
  • Junod
  • Just - Evotec Biologics
  • juvenile idiopathic arthritis
  • Topics
  • Analytical and bioanalysis
  • Bioprocessing and biomanufacturing
  • Quality, microbiology and contamination control
  • Regulation and compliance
  • Formulation and drug delivery
  • Packaging, containers and labelling
  • Advertising & Editorial
  • Advertising opportunities
  • Media planner
  • Advertising tech specs
  • Advisory board
  • Information for authors
  • Reuse policy
  • Information
  • About us
  • Company information
  • Careers
  • Terms and conditions
  • Privacy policy
  • Cookie policy
Leading the conversation in pharma manufacturing
Find us on social media:
  • Topics A-Z
  • Writers A-Z
  • © 2026 European Pharmaceutical Review

Site powered by Webvision Cloud